Email Us:
To contact Trxade, please complete the form below and a team member will reply as soon as possible.
Latest TRxADE News
FDA Stay Informed RSS
- Safety, Efficacy, and Quality Remain Top Priorities as We Continue Our Work to Expand Access to Cost-Saving Generic Drugs for the American Public June 25, 2019The agency continues to work to ensure a supply of safe, effective, and cost-saving generic drugs, each manufactured under our rigorous quality standards. Generic drugs account for 90 percent of the prescriptions dispensed in the U.S., saving the health care system about $1.67 trillion.FDA
FiercePharma News RSS
- GSK wins speedy FDA Zejula review in ovarian cancer niche June 24, 2019Late-stage ovarian cancer patients have few options, but now the FDA is reviewing GSK's Zejula for the patient group. GSK picked up the med in last year's Tesaro buyout.Eric Sagonowsky